Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02675205

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild (from the registry)
Registry
  • NCT NCT02675205
  • EudraCT 2014-005720-10
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02675205. Randomized; no masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2020-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm
Acronym
TIC-TAC
Condition
Cerebral Aneurysm
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Ticagrelor
Intervention (Drug)
aspirin
Lead sponsor
Fondation Ophtalmologique Adolphe de Rothschild (class: research network)

Record details

Record id
cardio:ct-nct02675205
Content hash
e476b73783e7fea0399a9ce1c3d1eb9f62e222b3b51d0e42f6d7ffa1d3812b1c